GCS Holdings, Inc. (TPEX:4991)

Market Cap	19.20B
Revenue (ttm)	1.88B
Net Income (ttm)	-105.57M
Shares Out	113.60M
EPS (ttm)	-0.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	731,000
Average Volume	13,402,291
Open	174.50
Previous Close	169.00
Day's Range	170.50 - 185.50
52-Week Range	36.60 - 179.00
Beta	0.25
RSI	61.62
Earnings Date	Aug 3, 2025

About Theseus Pharmaceuticals

GCS Holdings, Inc., together with its subsidiaries, manufactures and sells compound semiconductor wafer and foundry related services in China, the United States, Taiwan, and internationally. It also researches, develops, manufactures, and sells optoelectronics technology products and optical chips, as well as grants royalty rights for intellectual property. In addition, the company engages in the wholesaling and retailing of electronic components; provision of product design, research development, and outsourcing management services; manufactur...

• Industry: Semiconductor Equipment & Materials
• Sector: Technology
• Founded: 1997
• Country: Cayman Islands
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4991

Financial Performance

In 2024, GCS Holdings's revenue was 1.75 billion, an increase of 29.57% compared to the previous year's 1.35 billion. Losses were -236.99 million, -70.09% less than in 2023.